Log In
Print
BCIQ
Print
Print this Print this
 

Cologic, gTA test

  Manage Alerts
Collapse Summary General Information
Company Phenomenome Discoveries Inc.
DescriptionColorectal cancer screening test which uses a mass spectrometry method to quantify the level of gastrointestinal tract serum fatty acid-446 (GTA-446) in blood
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetermine diagnostic accuracy in detecting colorectal cancer (CRC) in asymptomatic persons and determine effects of tumor resection in CRC positive patient's pre and post-surgery; Evaluate the predictive power of blood gTA levels as a pre-colonoscopy screening procedure
Regulatory Designation

Partner

CML Healthcare Inc.; Polymedco Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today